Sunscreen products: Rationale for use, formulation development and regulatory considerations

被引:73
|
作者
Geoffrey, Kiriiri [1 ]
Mwangi, A. N. [1 ]
Maru, S. M. [1 ]
机构
[1] Univ Nairobi, Sch Pharm, Dept Pharmaceut & Pharm Practice, POB 19676-00202, Nairobi, Kenya
关键词
Sunscreens; Photoprotection; Ultraviolet rays; UVA; UVB; Sun protection factor (SPF); Water resistance; Minimum erythemal dose (MED); SKIN-CANCER; ULTRAVIOLET-RADIATION; PROTECTION FACTORS; SUN EXPOSURE; LIGHT; PREVENTION; EFFICACY;
D O I
10.1016/j.jsps.2019.08.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The association of sunrays with skin damage have been known since medieval times. The description of the electromagnetic spectrum facilitated the identification of the ultraviolet light spectrum as being responsible for skin damage resulting from prolonged skin exposure. Sunscreens have been used since ancient civilizations with various measures to limit exposure to sun exposure being employed. Awareness of the risks associated with sunrays has been increasing in the last century, and as a result, the science, technologies, and formulation have advanced significantly. The use of sunscreen products continues rising as government health agencies seek to contain increasing cases of UV induced melanomas. Recreational sunbathing and artificial tanning have increased the risk for these diseases significantly. This review article sought to expound the scientific basis of sunscreen use, the classification, formulation, quality control and regulation across the different countries around the world. The literature review was conducted on Google scholar, PubMed, SCOPUS, Cochrane, BMJ, SCIELO among others. (C) 2019 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.
引用
收藏
页码:1009 / 1018
页数:10
相关论文
共 50 条
  • [21] Inorganic nanoparticles in dermopharmaceutical and cosmetic products: Properties, formulation development, toxicity, and regulatory issues
    Mascarenhas-Melo, Filipa
    Mathur, Ankita
    Murugappan, Sivasubramanian
    Sharma, Arpana
    Tanwar, Kalpita
    Dua, Kamal
    Singh, Sachin Kumar
    Mazzola, Priscila Gava
    Yadav, Dokkari Nagalaxmi
    Rengan, Aravind Kumar
    Veiga, Francisco
    Paiva-Santos, Ana Claudia
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2023, 192 : 25 - 40
  • [22] Regulatory considerations for animal studies of biomaterial products
    Cheng, Maobo
    Liu, Wenbo
    Zhang, Jiazhen
    Zhang, Song
    Guo, Zhaojun
    Liu, Lu
    Tian, Jiaxin
    Zhang, Xiangmei
    Cheng, Jin
    Liu, Yinghui
    Deng, Gang
    Gao, Guobiao
    Sun, Lei
    BIOACTIVE MATERIALS, 2022, 11 : 52 - 56
  • [23] Regulatory considerations for researchers of natural products.
    Braverman, M
    Kunkel, DL
    Baron, JJ
    Holm, RE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U32 - U32
  • [24] Regulatory Considerations for Fecal Microbiota Transplantation Products
    Carlson, Paul E., Jr.
    CELL HOST & MICROBE, 2020, 27 (02) : 173 - 175
  • [25] REGULATORY CONSIDERATIONS WHEN DEVELOPING BIOLOGICAL PRODUCTS
    KOZAK, RW
    DURFOR, CN
    SCRIBNER, CL
    CYTOTECHNOLOGY, 1992, 9 (1-3) : 203 - 210
  • [26] Cannabidiol Products: Review of the Regulatory and Clinical Considerations
    Hawes, Emily M.
    Lee, Cameron R.
    Brackney, Dana E.
    Ensley, Tucker G.
    Kidd, Julie
    Page, Cristen
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2020, 16 (10): : 747 - 755
  • [27] Developing Products to meet Global Allergy Patient Needs: Product Development and Regulatory Considerations
    De Kam, P. -J.
    ALLERGOLOGIE, 2024, 47 (06)
  • [28] Regulatory Considerations and Testing Strategies for Cell and Tissue Based Products During Product Development
    Risdahl, J. M.
    TISSUE ENGINEERING PART A, 2015, 21 : S185 - S185
  • [29] CONSIDERATIONS IN THE FORMULATION OF A THEORY OF AESTHETIC DEVELOPMENT
    KAPLAN, BJ
    JOURNAL OF AESTHETIC EDUCATION, 1982, 16 (04): : 93 - 96
  • [30] Pediatric drug development: formulation considerations
    Ali, Areeg Anwer
    Charoo, Naseem Ahmad
    Abdallah, Daud Baraka
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2014, 40 (10) : 1283 - 1299